Literature DB >> 12622348

Sensitization to cocaine in pigeons: interaction with an operant contingency.

Jonathan W Pinkston1, Marc N Branch.   

Abstract

A 2-part study with pigeons investigated the role of an explicit operant contingency in determining how cocaine interacts with locomotor activity. In Part 1, pigeons pecked on a fixed-ratio-20 schedule of food presentation. In Part 2, different pigeons were studied without opportunity to peck for food. After determination of cocaine's initial effects, pigeons were exposed to daily administrations of a locomotion-increasing dose of cocaine. Locomotor sensitization was evident in the pigeons of Part 2, and tolerance developed to cocaine's effects on key pecking in the pigeons of Part 1. Locomotor sensitization was generally not evident in the pigeons of Part 1. These results suggest that explicitly conditioned operant behavior may compete with behavior sensitized by prolonged exposure to cocaine.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12622348     DOI: 10.1037//1064-1297.11.1.102

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  4 in total

1.  Acute and chronic effects of cocaine on the spontaneous behavior of pigeons.

Authors:  Jonathan W Pinkston; Marc N Branch
Journal:  J Exp Anal Behav       Date:  2010-07       Impact factor: 2.468

2.  Effects of D-amphetamine and ethanol on variable and repetitive key-peck sequences in pigeons.

Authors:  Ryan D Ward; Ericka M Bailey; Amy L Odum
Journal:  J Exp Anal Behav       Date:  2006-11       Impact factor: 2.468

3.  The nicotine + alcohol interoceptive drug state: contribution of the components and effects of varenicline in rats.

Authors:  Patrick A Randall; Reginald Cannady; Joyce Besheer
Journal:  Psychopharmacology (Berl)       Date:  2016-06-22       Impact factor: 4.530

4.  Limitations to the generality of cocaine locomotor sensitization.

Authors:  Julie A Marusich; Marc N Branch; Jesse Dallery
Journal:  Exp Clin Psychopharmacol       Date:  2008-08       Impact factor: 3.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.